Recruiting

NCT Number: NCT05592132

Use of Virtual Reality in Pain Management in Pediatric Oncology

DOREVI is a monocentric randomized controlled study that will evaluate the efficacy of virtual reality helmets for pain prevention during invasive care on 78 oncologic pediatric patients. Two groups of children (between 6 and 11 and between 12 and 18 years old) will be randomized to use helmet plus standard care or standard care alone during invasive procedures (central venous catheter puncture, lumbar puncture, or bone marrow aspiration). The pain intensity will be evaluated using a visual analogic scale during three invasive procedures, and results will be compared between the patients with or without virtual reality.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Pediatric Tumor Neoplasms

Age range

6 year–18 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU de La Réunion

Saint-Denis, 97400, Reunion

Location status: Recruiting

Location contact

Yves REGUERRE, MD

CONTACT

Yves REGUERRE, MD

PRINCIPAL_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

patient who tolerates the virtual reality headset
patient followed in pediatric oncology
patient with a diagnosis of benign tumor or cancer
patient who needs to have painful medical procedure during their treatment
patient whose parents have signed the informed consent
patient affiliated with social security or equivalent

Exclusion criteria

patient with visual or hearing impairement
patient with epilepsy or other neurological disease
patient with psychiatric disease

Treatment and study plan

Virtual reality headset

Other

Each patient in this treatment group will use a virtual reality headset during 3 procedures. During each procedure, the pain level will be assessed and compared with the assessed group.

Primary outcomes

Self pain evaluation

Time frame: before blood sampling on catheter with implantable chamber

Pain will be assessed by the analogic visual scale (minimal score = 0 (no pain) , maximal score = 10 (maximal pain))

Study contacts

Contact information is provided by the study sponsor or research team.

Emilie TECHER

CONTACT

[email protected]

+262262906289

Yves REGUERRE

CONTACT

[email protected]

+262262905676

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de la Réunion

Other

Registry information

Official study title

Use of Virtual Reality in Pain Management During Invasive Gestures in Pediatric Oncology: Randomized Controlled Trial

Acronym: DOREVI

Important dates

Study start: 2023
Primary completion: 2026
Study completion: 2026
First posted: Oct 24, 2022
Registry last updated: Mar 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed